ICD-10 Coding for Pancreatic Neuroendocrine Tumor(C25.0, C25.4, C25.4B)
Explore detailed ICD-10 coding guidelines for pancreatic neuroendocrine tumors, including documentation requirements and common coding pitfalls.
Complete code families applicable to Pancreatic Neuroendocrine Tumor
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C25.4 | Malignant neoplasm of endocrine pancreas | Use for nonfunctional pancreatic neuroendocrine tumors with confirmed pancreatic origin. |
|
| C7A.094 | Malignant neuroendocrine tumor of foregut | Use for foregut neuroendocrine tumors when pancreatic origin is not confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPancreatic Neuroendocrine Tumor
Alternative codes to consider when ruling out similar conditions
Use for confirmed pancreatic origin tumors.
Documentation & Coding Risks
Avoid these common issues when documenting Pancreatic Neuroendocrine Tumor.
Omitting tumor grade in documentation
Impact
Clinical: Impacts treatment decisions and prognosis., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to insufficient documentation.
Mitigation
Ensure pathology reports include tumor grade and Ki-67 index., Educate staff on documentation standards.
Incorrect Primary Code
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation
Use C25.4 for pancreatic-origin NETs, not C7A.094.
Code Selection
Impact
Risk of selecting incorrect primary code for pancreatic NETs.
Mitigation
Regular training on code differentiation and documentation requirements.